We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » The Federal Government’s $600M Contract With Troubled Vaccine Manufacturing Plant Emergent is No More
The Federal Government’s $600M Contract With Troubled Vaccine Manufacturing Plant Emergent is No More
Following a year in which vaccine manufacturing plant Emergent BioSolutions spent many months in the headlines for botching 75 million Johnson & Johnson (J&J) COVID-19 vaccines, the federal government and the troubled company have parted ways.